Press release
Central Nervous System (CNS) Therapeutics Market to Witness Continued Growth by 2033 - Allied Market Research
In 2023, the global Central Nervous System (CNS) Therapeutics Market was valued at $114.2 billion and is projected to reach $199.1 billion by 2033, reflecting a CAGR of 5.7% from 2024 to 2033. The Central Nervous System (CNS) Therapeutics Market has witnessed significant growth in recent years, driven by an increasing prevalence of neurological disorders and advancements in treatment methodologies. This article provides an in-depth analysis of the market, focusing on key statistics, growth factors, market segmentation, and leading industry players.Get Sample PDF Copy: https://www.alliedmarketresearch.com/request-sample/A305147
Central Nervous System (CNS) Therapeutics Market Growth Factors
Several factors contribute to the robust growth of the Central Nervous System (CNS) Therapeutics Market:
1. Rising Prevalence of Neurodegenerative Disorders: The increasing incidence of conditions such as Alzheimer's disease, Parkinson's disease, and multiple sclerosis has heightened the demand for effective therapeutics. For instance, over 1.8 million people globally are affected by multiple sclerosis.
2. Advancements in Research and Development: Continuous efforts in R&D have led to the discovery of novel drugs and treatment approaches, enhancing the efficacy of CNS therapeutics.
3. Aging Population: The global increase in the elderly population, who are more susceptible to neurological disorders, has escalated the need for CNS therapeutics.
4. Improved Healthcare Infrastructure: Developments in healthcare facilities, particularly in emerging economies, have facilitated better access to CNS treatments.
Have Any Query? Ask Our Experts: https://www.alliedmarketresearch.com/purchase-enquiry/A305147
Central Nervous System (CNS) Therapeutics Market Segmentation
The Central Nervous System (CNS) Therapeutics Market can be segmented based on disease type and region.
By Disease Type:
• Neurodegenerative Diseases: This segment dominated the market in 2023 and is expected to maintain its leading position during the forecast period. The surge in prevalence of diseases like Alzheimer's and Parkinson's contributes to this dominance.
• Neurovascular Diseases: Includes conditions affecting the blood vessels of the brain and spinal cord.
• CNS Trauma: Encompasses injuries to the brain and spinal cord resulting from external forces.
• Mental Health: Covers psychiatric disorders such as depression, anxiety, and schizophrenia.
• Infectious Diseases: Involves CNS infections like meningitis and encephalitis.
• CNS Cancer: Pertains to malignancies within the central nervous system.
• Others: Includes miscellaneous CNS disorders not categorized above.
By Region:
• North America: Held the largest revenue share in 2023, attributed to a high geriatric population and well-developed healthcare infrastructure.
• Europe: Exhibits significant market presence with ongoing research and healthcare advancements.
• Asia-Pacific: Anticipated to grow at the fastest rate during the forecast period, driven by a large patient pool and increasing prevalence of mental health disorders.
• LAMEA (Latin America, Middle East, and Africa): Emerging market with potential growth opportunities due to improving healthcare facilities.
Key Players in the Central Nervous System (CNS) Therapeutics Market
The Central Nervous System (CNS) Therapeutics Market features several prominent companies:
• Biogen Inc.
• Johnson & Johnson
• Eli Lilly and Company Inc.
• Merck & Co. Inc.
• F. Hoffmann-La Roche
• Novartis AG
• Takeda Pharmaceuticals
• Viatris
• UCB
• Teva Pharmaceutical Industries Ltd.
The Central Nervous System (CNS) Therapeutics Market is poised for substantial growth, driven by the increasing prevalence of neurological disorders, advancements in research and development, and an aging global population. Market segmentation reveals the dominance of neurodegenerative diseases and highlights the rapid growth anticipated in the Asia-Pacific region. Leading pharmaceutical companies continue to invest in innovative treatments, further propelling market expansion.
Read Full Market Synopsis: https://www.alliedmarketresearch.com/central-nervous-system-cns-therapeutics-market-A305147
Thanks for reading this article; you can also get an individual chapter-wise sections or region-wise report versions like North America, LATAM, Europe, or Southeast Asia.
Contact Us:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
About Us:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Central Nervous System (CNS) Therapeutics Market to Witness Continued Growth by 2033 - Allied Market Research here
News-ID: 4029289 • Views: …
More Releases from Allied Market Research

Global Urinary Drainage Bags Market: Trends, Growth, and Insights to 2031
The global urinary drainage bags market is experiencing robust growth, with its market size valued at $1.4billion in 2021 and projected to reach $2billion by 2031. This expansion represents a compound annual growth rate (CAGR) of 3.8% from 2021 to 2031, highlighting the increasing demand for these essential medical devices.
Get a Sample Copy of this Report: https://www.alliedmarketresearch.com/request-sample/A17529
What Are Urinary Drainage Bags?
Urinary drainage bags are specialized medical devices designed to collect…

Cream Powder Market to Reach $8.9 Billion by 2031 with 6.4% CAGR
The global cream powder industry was estimated at $4.8 billion in 2021 and is expected to hit $8.9 billion by 2031, registering a CAGR of 6.4% from 2022 to 2031.
The cream powder market is experiencing growth due to various factors, including the increasing popularity of bakeries and HoReCa (hotels, restaurants, and cafes) and rising consumer demand for natural products. The dairy-based segment is a significant contributor to the market's growth…

Micro Drone Market Valued at $6.71 Billion in 2020, Expected to Reach $28.91 Bil …
The global micro drone industry generated $6.71 billion in 2020, and is expected to reach $28.91 billion in 2030, witnessing a CAGR of 17.2% from 2021 to 2030. The report provides an extensive analysis of changing market dynamics, top segments, top investment pockets, regional landscape, value chain, and competitive scenario.
Increased operational efficiency and rise in demand for improved surveillance drive the growth of the global micro drone market. However, strict…

Microwavable Foods Market to reach $230.93 billion by 2031, growing at a CAGR of …
The global microwaveable foods industry was accounted for $120.45 billion in 2020, and is expected to reach $230.93 billion by 2031, growing at a CAGR of 5.6% from 2022 to 2031.
Rise in popularity of fast-food restaurants and large population base coupled with increase in number of quick-service restaurants drive the global microwaveable foods market. However, lack of awareness about microwavable foods hinders the market growth. On the contrary, rise in…
More Releases for CNS
CNS promotes craftsmanship of towel production in China
[https://youtu.be/oP-N73N0ey0]
China News Service (CNS) issued a press release and a promo video here on Wednesday to promote the unique craftsmanship of towel production in Gaoyang [https://youtu.be/oP-N73N0ey0] County of Chinese northern Hebei Province.
According to the CNS press release, Gaoyang is the largest hub of towel production in China, where one out of every three towels in the nation originates. More than 4200 textile enterprises are competing to flourish in this region,…
Gene Therapy in CNS Disorder Market - Unlocking the Potential of Gene Therapy: T …
Newark, New Castle, USA: The "Gene Therapy in CNS Disorder Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Gene Therapy in CNS Disorder Market: https://www.growthplusreports.com/report/gene-therapy-in-cns-disorder-market/8886
This latest report…
Central Nervous System (CNS) Therapeutic Market Central Nervous System (CNS) The …
MARKET INTRODUCTION
The central nervous system (CNS) is the control panel of the body, which is responsible for cognition, movement, senses and emotions. Central nervous system diseases, is a group of neurological disorders that affect the structure or function of the brain or spinal cord, which collectively form the central nervous system (CNS). The CNS diseases include neurodegenerative diseases, neurodevelopmental diseases and traumatic injuries. Drugs such as analgesics, anesthetics, nervous system…
Neuro Critical Care Market Insights in terms of volume and value 2018 to 2028(Mo …
Neuro critical care is an emerging field that combines the specialties that link neurology, neurosurgery, and critical care. Just as the field has evolved from primary focus on post-operative care to elective neurosurgical patients, the focus towards the resuscitation of neurological emergency cases such as traumatic brain injury or subarachnoid hemorrhage, which remain a clinical challenge. The neuro critical care market is strongly driven by the increasing focus, awareness, and…
US CNS Disorders Drug Pipeline Insight 2014
The Central Nervous System (CNS) disorders market in US is one of the largest segments of pharmaceuticals industry. In US, the numbers of CNS disorders have increased at an alarming rate, while the available therapies were unable to meet the market requirements. There has been steady to rapid growth in the market for CNS disorder, especially over the past two decades. The market for CNS therapies is one of the…
CNS Therapeutics Market Research Report 2016
“Global CNS Therapeutics Market Research Report 2016” Order This Report by calling BigMarketResearch.com at +1-971-202-1575
Notes:
Production, means the output of CNS Therapeutics
Revenue, means the sales value of CNS Therapeutics
This report studies CNS Therapeutics in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering
Pfizer, Inc. (USA)
Johnson & Johnson (USA)
Bristol-Myers Squibb…